- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,620 | 05.07.24 20:19:17 | -0,230 | -0,18% | 125,610 | 125,630 | 127,690 | 125,850 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 83,615 | 05.07.24 20:10:27 | +0,915 | +1,11% | 83,340 | 83,640 | 84,900 | 82,700 |
